FAIRFIELD, N.J., Jan. 23, 2012 /PRNewswire/ -- Aperture Health,
Inc. (OTC: APRE) announced that it has achieved full OTC Pink
status with its public disclosure and reporting of interim
financial data in conjunction with current required disclosure
documentation for OTC PINK listing compliance.
Aperture Health, Inc., a Nevada Corporation, through the
Company's wholly owned subsidiary, Triad Therapeutics, Inc.,
provides specialized home healthcare services to patient clients
requiring intravenous therapy including antibiotics, pain
management, total nutritional support, hydration, steroids,
immunoglobulins and IV catheter insertions and maintenance. The
Company provides a complete solution to patients including the
preparation and delivery of sterile compounded IV medications,
supplies and equipment, along with specialized nursing care and
teaching of the patient and/or caregivers on the administration of
therapies as prescribed by a physician.
James Hennig, R.Ph, Chief
Executive Officer and Chairman of the Board of Directors commented,
"We are very pleased to qualify and be designated "OTC PINK Current
Information" based upon our commitment and efforts to provide the
investing public with as much relevant financial and disclosure
information about Aperture Health and its' business."
Safe Harbor
Certain statements in this news release are forward-looking,
including (without limitation) growing revenues and earnings,
expected results from current projects and attracting new
business. Undue reliance should not be placed on such
forward-looking statements because the matters they describe are
subject to known and unknown risks, uncertainties and other
unpredictable factors, many of which are beyond the Company's
control. The Company's actual results, performance and trends could
differ materially from those indicated or implied by such
statements as a result of various factors, including (without
limitation) the continued strengthening of Triad's selling and
marketing functions, continued customer satisfaction, contract
renewal, new product development, continued availability of capable
dedicated personnel, continued cost management, success and
availability of acquisitions, availability of financing and other
factors, as well as by factors applicable to most companies such as
general economic, competitive and other business and civil
conditions. Information regarding certain of those and other
risk factors and cautionary statements that could affect future
results, performance or trends is discussed in the Company's OTC
Disclosure Statement and unaudited management financials posted on
www.pinksheets.com . All of the Company's forward-looking
statements are expressly qualified by all such risk factors and
other cautionary statements. The information set forth herein
speaks only as of the date hereof.
SOURCE Aperture Health, Inc.